RTI Surgical Holdings Inc. (RTIX)

4.28
NASDAQ : Health Technology
Prev Close 4.41
Day Low/High 4.25 / 4.49
52 Wk Low/High 3.51 / 6.15
Avg Volume 258.30K
Exchange NASDAQ
Shares Outstanding 73.90M
Market Cap 325.89M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
RTI Surgical™ Unveils PACK Precision Allograft Cartilage Instrument Kit At AOSSM Annual Meeting

RTI Surgical™ Unveils PACK Precision Allograft Cartilage Instrument Kit At AOSSM Annual Meeting

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is unveiling the new Precision Allograft Cartilage Kit (PACK) at the American Orthopaedic Society for Sports Medicine (AOSSM) ...

RTI Surgical™ Announces First Implantation Of Strips Configuration For Map3® Cellular Allogeneic Bone Graft

RTI Surgical™ Announces First Implantation Of Strips Configuration For Map3® Cellular Allogeneic Bone Graft

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is pleased to announce that the first human implantation of the company’s map3® Cellular Allogeneic Bone Graft ...

RTI Surgical Offers Surgeon Education Symposium Highlighting The Future Of Spine Surgery

RTI Surgical Offers Surgeon Education Symposium Highlighting The Future Of Spine Surgery

RTI Surgical™ Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it will host a surgeon education symposium titled Surgical Pioneers: A Debate on the Future of Spine Surgery.

RTI Surgical™ Announces 2014 First Quarter Results

RTI Surgical™ Announces 2014 First Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, reported operating results for the first quarter of 2014 as follows: First Quarter Highlights: ...

RTI Surgical™ Announces Launch Of Streamline® OCT System

RTI Surgical™ Announces Launch Of Streamline® OCT System

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, announced today the full market launch of the Streamline ® OCT System.

RTI Surgical® Schedules 2014 First Quarter Earnings Conference Call For April 24, 2014

RTI Surgical® Schedules 2014 First Quarter Earnings Conference Call For April 24, 2014

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the first quarter 2014 on Thursday, April 24, 2014, prior to the market open.

Map3 Cellular Allogeneic Bone Graft Is A Natural And Safe Alternative To Autograft That Supports The Body's Innate Healing Mechanisms And Provides The Scaffold And Signals For Neo-vascularization And Bone Growth (Photo: Business Wire)

Map3 Cellular Allogeneic Bone Graft Is A Natural And Safe Alternative To Autograft That Supports The Body's Innate Healing Mechanisms And Provides The Scaffold And Signals For Neo-vascularization And Bone Growth (Photo: Business Wire)

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is launching two new biological solutions at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans...

RTI Surgical™ Receives CE Mark Approval For Fortiva™ Porcine Dermis

RTI Surgical™ Receives CE Mark Approval For Fortiva™ Porcine Dermis

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, announced today that the company received approval to CE mark Fortiva™ Porcine Dermis and will begin distribution throughout ...

RTI Surgical™ Announces Launch Of Two New Spine Systems: Aspect ® Anterior Cervical Plate System And MaxFuse™ VBR System

RTI Surgical™ Announces Launch Of Two New Spine Systems: Aspect ® Anterior Cervical Plate System And MaxFuse™ VBR System

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, announced today the full market launch of the MaxFuse ™ Vertebral Body Replacement System and the Aspect® Anterior Cervical...

RTI Surgical® Announces Renewal Of Supply And Distribution Agreement With Zimmer, Inc. For Its Trauma Business

RTI Surgical® Announces Renewal Of Supply And Distribution Agreement With Zimmer, Inc. For Its Trauma Business

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, announced today that the company’s wholly owned subsidiary, Pioneer Surgical Technology Inc.

RTI Surgical™ Announces 2013 Fourth Quarter, Full Year Results, 2014 Financial Guidance

RTI Surgical™ Announces 2013 Fourth Quarter, Full Year Results, 2014 Financial Guidance

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2013 as follows: Quarterly Highlights: ...

RTI Surgical Schedules 2013 Fourth Quarter, Year End Earnings And Conference Call For February 13, 2014

RTI Surgical Schedules 2013 Fourth Quarter, Year End Earnings And Conference Call For February 13, 2014

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the fourth quarter and year end 2013 on Thursday, Feb.

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

Keep these under-$10 health care stocks on your radar.

RTI Surgical™ Announces Agreement To Supply Complete Surgical Specialties Portfolio To Yankee Alliance Members

RTI Surgical™ Announces Agreement To Supply Complete Surgical Specialties Portfolio To Yankee Alliance Members

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading global surgical implant company, announced a new agreement with Yankee Alliance, a group purchasing organization with more than 14,700 members.

RTIX: Insiders Vs. Shorts

RTIX: Insiders Vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 10/15/2013 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 9.72 "days to cover" versus the median component at 4.95.

RTI Surgical Announces Successful Resolution To FDA Warning Letter For Alachua, Fla. Facility

RTI Surgical Announces Successful Resolution To FDA Warning Letter For Alachua, Fla. Facility

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that the company has received a close-out letter from the Food and Drug Administration (FDA) verifying effective ...

RTI Surgical™ Announces 2013 Third Quarter Results

RTI Surgical™ Announces 2013 Third Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, reported operating results for the third quarter of 2013 as follows: Quarterly Highlights: ...

RTI Surgical™ Announces Preliminary Third Quarter 2013 Revenues

RTI Surgical™ Announces Preliminary Third Quarter 2013 Revenues

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today preliminary revenue results for the third quarter ended Sept.

4 Stocks Under $10 in Breakout Territory

4 Stocks Under $10 in Breakout Territory

These stocks are within range of triggering breakout trades.

RTI Surgical™ Announces First Implantation Of Map3™ Cellular Allogeneic Bone Graft In A Foot And Ankle Procedure

RTI Surgical™ Announces First Implantation Of Map3™ Cellular Allogeneic Bone Graft In A Foot And Ankle Procedure

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, is pleased to announce the first implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant in a foot and ankle ...

First Week Of April 2014 Options Trading For RTI Surgical (RTIX)

First Week Of April 2014 Options Trading For RTI Surgical (RTIX)

Investors in RTI Surgical, Inc. saw new options begin trading this week, for the April 2014 expiration.

RTI Surgical® Announces Successful Outcome To FDA Inspection Of Alachua, Fla. Facility

RTI Surgical® Announces Successful Outcome To FDA Inspection Of Alachua, Fla. Facility

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced that on Sept.

RTI Surgical™ Celebrates First Human Implantation Of Map3™ Cellular Allogeneic Bone Graft

RTI Surgical™ Celebrates First Human Implantation Of Map3™ Cellular Allogeneic Bone Graft

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce that the first human implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant was...

RTI Surgical™ Announces Launch Of Tritium™ Sternal Cable Plating System

RTI Surgical™ Announces Launch Of Tritium™ Sternal Cable Plating System

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, announced today the full market launch of the Tritium Sternal Cable Plating (SCP) System for closing median sternotomies ...

RTI Surgical Announces 2013 Second Quarter Results

RTI Surgical Announces 2013 Second Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, reported operating results for the second quarter of 2013 as follows: Quarterly Highlights: ...

RTI Surgical Schedules 2013 Second Quarter Earnings And Conference Call For August 6, 2013

RTI Surgical Schedules 2013 Second Quarter Earnings And Conference Call For August 6, 2013

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the second quarter 2013 on Tuesday, August 6, 2013...

RTI Biologics® Completes Acquisition Of Pioneer® Surgical Technology

RTI Biologics® Completes Acquisition Of Pioneer® Surgical Technology

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it has completed the acquisition of Pioneer® Surgical Technology (Pioneer).

RTI Biologics Inc. Stock Downgraded (RTIX)

RTI Biologics Inc. Stock Downgraded (RTIX)

RTI Biologics (Nasdaq:RTIX) has been downgraded by TheStreet Ratings from from a buy to hold.

Ratings Changes To Be Publicly Issued on 7/8/13

Upgrades: ACLS, BKR, GCAP, LBTYK Downgrades: RTIX Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

RTI Biologics Inc. Stock Upgraded (RTIX)

RTI Biologics Inc. Stock Upgraded (RTIX)

RTI Biologics (Nasdaq:RTIX) has been upgraded by TheStreet Ratings from a hold to buy.

TheStreet Quant Rating: C (Hold)